fon-2021-1367 – First-line gemcitabine plus nab-paclitaxel versus FOLFIRINOX for metastatic pancreatic cancer in a real-world population
收藏数据链接：
官方服务：
资源简介：
Table S1 Hazard Ratios with and without Inverse Probability Weights Table S2 Multivariate Analysis: Prognostic Factors for Overall Survival
创建时间：
2022-05-17
